BLIS Technologies Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
47
- Stock Symbol
-
BLT
- Share Price
-
$0.01
- (As of Friday Closing)
BLIS Technologies General Information
Description
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.
Contact Information
Website
www.blis.co.nzCorporate Office
- Post Box 2208
- South Dunedin
- Dunedin, 9044
- New Zealand
Corporate Office
- Post Box 2208
- South Dunedin
- Dunedin, 9044
- New Zealand
BLIS Technologies Stock Performance
As of 13-Nov-2026, BLIS Technologies’s stock price is $0.01. Its current market cap is $17.7M with 1.28B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.01 | $0.01 | $17.7M | 1.28B | 483K |
BLIS Technologies Financials Summary
As of 31-Mar-2026, BLIS Technologies has a trailing 12-month revenue of $7.87M.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 5,627 | 5,627 | 5,364 | 8,550 |
| Revenue | 7,865 | 7,865 | 6,840 | 6,386 |
| EBITDA | 582 | 582 | 626 | 518 |
| Net Income | 406 | 406 | 496 | 393 |
| Total Assets | 8,556 | 8,556 | 8,157 | 7,713 |
| Total Debt | 251 | 251 | 336 | 232 |
BLIS Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BLIS Technologies Patents
BLIS Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025904966-A0 | Treatment of pathogenic bacteria in non-human animals | Pending | 21-Oct-2025 | ||
| EP-4424178-A1 | Production of a probiotic composition | Pending | 03-Mar-2023 | ||
| US-12714731-B2 | Production of a probiotic composition | Active | 03-Mar-2023 | ||
| US-20240293479-A1 | Production of a probiotic composition | Active | 03-Mar-2023 | ||
| US-20260306558-A1 | Production of a probiotic composition | Pending | 03-Mar-2023 | A61K35/741 |
BLIS Technologies Signals
BLIS Technologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BLIS Technologies ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
BLIS Technologies FAQs
-
When was BLIS Technologies founded?
BLIS Technologies was founded in 2000.
-
Where is BLIS Technologies headquartered?
BLIS Technologies is headquartered in Dunedin, New Zealand.
-
What is the size of BLIS Technologies?
BLIS Technologies has 47 total employees.
-
What industry is BLIS Technologies in?
BLIS Technologies’s primary industry is Biotechnology.
-
Is BLIS Technologies a private or public company?
BLIS Technologies is a Public company.
-
What is BLIS Technologies’s stock symbol?
The ticker symbol for BLIS Technologies is BLT.
-
What is the current stock price of BLIS Technologies?
As of 13-Nov-2026 the stock price of BLIS Technologies is $0.01.
-
What is the current market cap of BLIS Technologies?
The current market capitalization of BLIS Technologies is $17.7M.
-
What is BLIS Technologies’s current revenue?
The trailing twelve month revenue for BLIS Technologies is $7.87M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process